Weekly CEO Buys Highlight

Details the CEO buys this past week from the following companies: American Assets Trust, Continental Resources, Odonate Therapeutics, LifePoint Health and Inphi

Author's Avatar
Mar 05, 2018
Article's Main Image

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

American Assets Trust CEO bought 302,116 shares

American Assets Trust Inc. (AAT, Financial) Chairman, CEO, President and 10% Owner Ernest S. Rady bought 302,116 shares during the past week at a price of $32.22.

American Assets Trust is a self-administered real estate investment trust based in the U.S. The company mainly invests in, operates and develops retail, office, residential and mixed-use properties in California, Oregon and Hawaii. The company has a market cap of $2.05 billion. Its shares traded at $31.76 with a price-earnings (P/E) ratio of 51.06 as of Mar. 2.

Net income for the fourth quarter of 2017 was $9.73 million compared to $12.41 million for the prior-year period.

Rady bought 94,155 shares on Feb. 21 at a price of $32.31; 105,101 shares on Feb. 23 at a price of $32.65; 64,775 shares on Feb. 27 at a price of $32.56; and 132,240 shares on March 2 at a price of $31.71. The price of the stock has increased by 0.16% since.

Continental Resources CEO bought 99,028 shares

Continental Resources Inc. (CLR, Financial) CEO, Chairman and 10% Owner Harold Hamm bought 99,028 shares on Feb. 27 at a price of $50.26. The price of the stock has decreased by 1.51% since.

Continental Resources is an independent crude oil and natural gas exploration and production company. It operates primarily in the Williston Basin and in southern Oklahoma. The company has a market cap of $18.37 billion. Its shares traded at $49.50 with a price-earnings (P/E) ratio of 23.46 as of March 2.

Net income for the fourth quarter of 2017 was $841.9 million.

Odonate Therapeutics CEO bought 81,745 shares

Odonate Therapeutics Inc. (ODT, Financial) CEO and 10% Owner Kevin C. Tang bought 81,745 shares during the past week at a price of $27.30.

Odonate Therapeutics is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. The company has a market cap of $743.69 million. Its shares traded at $27.21 as of Feb. 23.

Net loss for the three months ended Dec. 31, 2017, was $15.7 million compared to $1.9 million for the same period in 2016.

On Dec. 11, 2017, Odonate announced the closing of its initial public offering of 6.25 million shares of common stock at a public offering price of $24.00 per share.

Tang bought 128,255 shares on Feb. 16 at a price of $22.47; 39,083 shares on Feb. 22 at a price of $27.17; 28,612 shares on Feb. 27 at a price of $27.42; and 14,050 shares on March 1 at a price of $27.42. The price of the stock has decreased by 0.77% since.

LifePoint Health CEO bought 21,368 shares

LifePoint Health Inc. (LPNT, Financial) Chairman and CEO William F. Carpenter III bought 21,368 shares on Feb. 28 at a price of $46.80. The price of the stock has decreased by 1.07% since.

LifePoint Health is a health care company. The company, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The company has a market cap of $1.83 billion. Its shares traded at $46.30 with a price-earnings (P/E) ratio of 18.45 as of March 2.

Net loss for the fourth quarter of 2017 was $27 million.

Inphi CEO bought 25,000 shares

Inphi Corp. (IPHI, Financial) President and CEO Ford Tamer bought 25,000 shares on Feb. 23 at a price of $25.54. The price of the stock has increased by 15.58% since.

Inphi is engaged in designing, development and sale of high-speed analog connectivity components that operate to maintain, amplify and improve signal integrity in a wide variety of applications. The company has a market cap of $1.26 billion. Its shares traded at $29.52 as of March 2.

Net income for the fourth quarter of 2017 was almost break-even at $0.1 million, compared with net income of $19.1 million in the fourth quarter of 2016.

CFO John Edmunds sold 108,554 shares on Feb. 15 at a price of $25.25. The price of the stock has increased by 16.91% since.

Director Sam Srinivasan bought 5,000 shares on Feb. 16 at a price of $24.93. The price of the stock has increased by 18.41% since.

For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.